US Stock MarketDetailed Quotes

ELTX Elicio Therapeutics

Watchlist

4.950
+0.270+5.77%

Trading Jul 23 11:51 ET

53.31MMarket Cap-1350P/E (TTM)

Elicio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-48.94%-12.12M

-47.41%-32.69M

-36.01%-9.9M

3.75%-5.18M

-9.48M

-8.14M

7.35%-22.18M

-7.28M

-5.39M

-43.31%-23.94M

Net income from continuing operations

-47.30%-11.83M

-24.77%-35.2M

-34.55%-8.95M

-48.10%-10.66M

---7.56M

---8.03M

-6.85%-28.21M

---6.65M

---7.2M

-68.03%-26.4M

Operating gains losses

1,815.74%1.85M

-197.89%-927K

-102.44%-16K

-72.78%98K

---901K

---108K

1,688.07%947K

--657K

--360K

--52.96K

Depreciation and amortization

163.64%290K

10.69%1.17M

-2.72%286K

-7.14%273K

--501K

--110K

320.36%1.06M

--294K

29.99%251.45K

Other non cash items

----

-68.41%1.14M

-13.79%75K

--0

--719K

--342K

439.09%3.6M

--87K

--1.08M

1,208.12%667.05K

Change In working capital

-307.37%-2.76M

62.00%-57K

12.51%-1.63M

15,986.67%4.77M

---2.52M

---678K

-117.19%-150K

---1.86M

---30K

156.61%872.44K

-Change in prepaid assets

222.30%1.25M

61.04%-729K

-45.76%-688K

170.14%1.05M

---73K

---1.02M

-419.42%-1.87M

---472K

---1.5M

88.28%-360.21K

-Change in payables and accrued expense

-465.94%-3.7M

173.05%2.24M

151.45%266K

533.71%2.3M

---1.34M

--1.01M

-34.98%820K

---517K

---531K

-18.64%1.26M

-Change in other current assets

----

0.12%410.91K

-Change in other current liabilities

-49.69%-244K

-54.21%-825K

-50.96%-237K

-62.99%-251K

---174K

---163K

-21.75%-535K

---157K

---154K

-2.63%-439.43K

-Change in other working capital

86.79%-67K

-151.67%-742K

-35.47%-970K

--1.66M

---929K

---507K

--1.44M

---716K

----

Cash from discontinued investing activities

Operating cash flow

-48.94%-12.12M

-47.41%-32.69M

-36.01%-9.9M

3.75%-5.18M

---9.48M

---8.14M

7.35%-22.18M

---7.28M

---5.39M

-43.31%-23.94M

Investing cash flow

Cash flow from continuing investing activities

117.65%3K

95.11%-32K

-45K

30K

-17K

-24.49%-654K

-95K

-162.79%-525.36K

Net PPE purchase and sale

117.65%3K

95.11%-32K

--0

---45K

--30K

---17K

-24.49%-654K

---95K

--0

-162.79%-525.36K

Cash from discontinued investing activities

Investing cash flow

117.65%3K

95.11%-32K

--0

---45K

--30K

---17K

-24.49%-654K

---95K

--0

-162.79%-525.36K

Financing cash flow

Cash flow from continuing financing activities

9.80%11.02M

82.12%38.61M

-37.35%7M

-99.33%59K

21.51M

10.04M

9.32%21.2M

11.18M

8.78M

-22.62%19.39M

Net issuance payments of debt

--0

--10M

--0

--10M

--0

--14.03M

Net common stock issuance

--5.06M

--6.85M

--7M

--0

---150K

--0

--101.38K

Net preferred stock issuance

----

--0

----

327.07%21.12M

--11.11M

--8.84M

-80.07%4.95M

Proceeds from stock option exercised by employees

14,805.00%5.96M

54.88%127K

--0

198.36%60K

--27K

--40K

-21.36%82K

--65K

---61K

-57.54%104.28K

Net other financing activities

----

--21.64M

--3K

---1K

----

--210.6K

Cash from discontinued financing activities

Financing cash flow

9.80%11.02M

82.12%38.61M

-37.35%7M

-99.33%59K

--21.51M

--10.04M

9.32%21.2M

--11.18M

--8.78M

-22.62%19.39M

Net cash flow

Beginning cash position

69.97%14.3M

-16.24%8.41M

273.07%17.2M

1,739.06%22.36M

--10.3M

--8.41M

-33.54%10.05M

--4.61M

--1.22M

121.96%15.12M

Current changes in cash

-158.12%-1.1M

460.94%5.89M

-176.06%-2.89M

-252.37%-5.17M

--12.07M

--1.88M

67.84%-1.63M

--3.81M

--3.39M

-162.17%-5.07M

Effect of exchange rate changes

----

--0

--2K

----

--0

----

End cash Position

28.24%13.21M

69.97%14.3M

273.07%17.2M

--22.36M

--10.3M

-16.23%8.41M

--8.41M

--4.61M

-32.89%10.04M

Free cash flow

-48.63%-12.12M

-43.48%-32.76M

-34.26%-9.9M

2.91%-5.23M

---9.48M

---8.16M

6.67%-22.83M

---7.37M

---5.39M

-44.72%-24.46M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-48.94%-12.12M	-47.41%-32.69M	-36.01%-9.9M	3.75%-5.18M	-9.48M	-8.14M	7.35%-22.18M	-7.28M	-5.39M	-43.31%-23.94M
Net income from continuing operations	-47.30%-11.83M	-24.77%-35.2M	-34.55%-8.95M	-48.10%-10.66M	---7.56M	---8.03M	-6.85%-28.21M	---6.65M	---7.2M	-68.03%-26.4M
Operating gains losses	1,815.74%1.85M	-197.89%-927K	-102.44%-16K	-72.78%98K	---901K	---108K	1,688.07%947K	--657K	--360K	--52.96K
Depreciation and amortization	163.64%290K	10.69%1.17M	-2.72%286K	-7.14%273K	--501K	--110K	320.36%1.06M	--294K	--294K	29.99%251.45K
Other non cash items	----	-68.41%1.14M	-13.79%75K	--0	--719K	--342K	439.09%3.6M	--87K	--1.08M	1,208.12%667.05K
Change In working capital	-307.37%-2.76M	62.00%-57K	12.51%-1.63M	15,986.67%4.77M	---2.52M	---678K	-117.19%-150K	---1.86M	---30K	156.61%872.44K
-Change in prepaid assets	222.30%1.25M	61.04%-729K	-45.76%-688K	170.14%1.05M	---73K	---1.02M	-419.42%-1.87M	---472K	---1.5M	88.28%-360.21K
-Change in payables and accrued expense	-465.94%-3.7M	173.05%2.24M	151.45%266K	533.71%2.3M	---1.34M	--1.01M	-34.98%820K	---517K	---531K	-18.64%1.26M
-Change in other current assets	----	----	----	----	----	----	----	----	----	0.12%410.91K
-Change in other current liabilities	-49.69%-244K	-54.21%-825K	-50.96%-237K	-62.99%-251K	---174K	---163K	-21.75%-535K	---157K	---154K	-2.63%-439.43K
-Change in other working capital	86.79%-67K	-151.67%-742K	-35.47%-970K	--1.66M	---929K	---507K	--1.44M	---716K	----	----
Cash from discontinued investing activities
Operating cash flow	-48.94%-12.12M	-47.41%-32.69M	-36.01%-9.9M	3.75%-5.18M	---9.48M	---8.14M	7.35%-22.18M	---7.28M	---5.39M	-43.31%-23.94M
Investing cash flow
Cash flow from continuing investing activities	117.65%3K	95.11%-32K	0	-45K	30K	-17K	-24.49%-654K	-95K	0	-162.79%-525.36K
Net PPE purchase and sale	117.65%3K	95.11%-32K	--0	---45K	--30K	---17K	-24.49%-654K	---95K	--0	-162.79%-525.36K
Cash from discontinued investing activities
Investing cash flow	117.65%3K	95.11%-32K	--0	---45K	--30K	---17K	-24.49%-654K	---95K	--0	-162.79%-525.36K
Financing cash flow
Cash flow from continuing financing activities	9.80%11.02M	82.12%38.61M	-37.35%7M	-99.33%59K	21.51M	10.04M	9.32%21.2M	11.18M	8.78M	-22.62%19.39M
Net issuance payments of debt	--0	--10M	--0	--0	--0	--10M	--0	--0	--0	--14.03M
Net common stock issuance	--5.06M	--6.85M	--7M	--0	---150K	--0	--0	--0	--0	--101.38K
Net preferred stock issuance	----	--0	--0	--0	----	----	327.07%21.12M	--11.11M	--8.84M	-80.07%4.95M
Proceeds from stock option exercised by employees	14,805.00%5.96M	54.88%127K	--0	198.36%60K	--27K	--40K	-21.36%82K	--65K	---61K	-57.54%104.28K
Net other financing activities	----	--21.64M	--3K	---1K	----	----	----	----	----	--210.6K
Cash from discontinued financing activities
Financing cash flow	9.80%11.02M	82.12%38.61M	-37.35%7M	-99.33%59K	--21.51M	--10.04M	9.32%21.2M	--11.18M	--8.78M	-22.62%19.39M
Net cash flow
Beginning cash position	69.97%14.3M	-16.24%8.41M	273.07%17.2M	1,739.06%22.36M	--10.3M	--8.41M	-33.54%10.05M	--4.61M	--1.22M	121.96%15.12M
Current changes in cash	-158.12%-1.1M	460.94%5.89M	-176.06%-2.89M	-252.37%-5.17M	--12.07M	--1.88M	67.84%-1.63M	--3.81M	--3.39M	-162.17%-5.07M
Effect of exchange rate changes	----	--0	--0	--2K	----	----	--0	--0	--0	----
End cash Position	28.24%13.21M	69.97%14.3M	69.97%14.3M	273.07%17.2M	--22.36M	--10.3M	-16.23%8.41M	--8.41M	--4.61M	-32.89%10.04M
Free cash flow	-48.63%-12.12M	-43.48%-32.76M	-34.26%-9.9M	2.91%-5.23M	---9.48M	---8.16M	6.67%-22.83M	---7.37M	---5.39M	-44.72%-24.46M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall